Publications by authors named "C Koehn"
Introduction: The global coronavirus 2019 (COVID-19) pandemic created many challenges in healthcare provision. This study aimed to evaluate the global impact of the COVID-19 pandemic on people living with rheumatoid arthritis (RA).
Methods: The RA Narrative COVID-19 survey was conducted online among people with RA who resided in Brazil, Canada, France, Japan, and the US from August to September 2021.
Objective: To understand experiences related to rheumatoid arthritis (RA) care and propose service-level strategies to reduce and mitigate inequities for Black people living in Canada.
Methods: Purposive and respondent driven sampling was used to recruit participants for qualitative interviews to explore population factors relevant to RA care and challenges and facilitators for access to health care services, medications, and enacting preferred treatment plans. Thematic analysis was conducted using the Braun and Clarke method with inductive and deductive coding and critical race theory guiding analysis.
Objective: We aimed to advance understanding of how persons with rheumatoid arthritis (RA) experience decision-making about adopting public health measures during the COVID-19 pandemic.
Methods: Persons living with RA partnered throughout this nested qualitative study. One-to-one semistructured telephone interviews were conducted with participants with RA between December 2020 and December 2021.
Article Synopsis
- - The study aimed to analyze how exposure to immunosuppressive and immunomodulatory agents (IIAs) affects severe outcomes of COVID-19, using a large cohort from British Columbia, Canada, with participants aged 18 and older who tested positive for the virus.
- - It examined various types of IIAs, including traditional disease-modifying drugs, immunosuppressants, TNF inhibitor biologics, and glucocorticoids, looking for their impact on COVID-19 hospitalizations, ICU admissions, and deaths within 60 days of diagnosis.
- - Findings indicated that certain IIAs, notably mycophenolate mofetil (MMF), showed a significantly higher risk for COVID-19 hospitalizations and severe
Although biosimilar uptake has increased (at a variable pace) in many countries, there have been recent concerns about the long-term sustainability of biosimilar markets. The aim of this manuscript is to assess the sustainability of policies across the biosimilar life cycle in selected countries with a view to propose recommendations for supporting biosimilar sustainability. The study conducted a comparative analysis across 17 countries from North America, South America, Asia-Pacific, Europe and the Gulf Cooperation Council.
View Article and Find Full Text PDF